The Week in Review: March 9 – March 16, 2018

Friday, March 16, 2018 News Recap: Canada: Treatment: Fantastic news from both BC and Quebec this last week:  All restrictions to treatment under the respective provincial PharmaCare plans have been removed!! See Chronic hepatitis C medication now available for all British Columbians, and Quebec Expands Patient Access to Chronic Hepatitis C Therapies. Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hep...

Study shows shorter hepatitis C regimen effective in black patients

Boston, MA - A study by the Harvard Pilgrim Health Care Institute found that contrary to current hepatitis C treatment guidelines, an eight-week treatment regimen may be just as effective as 12 weeks in black patients. The new study of more than 2,600 patients in Kaiser Permanente's Northern California region also showed that more people overall could take advantage of the shorter treatment duration, which has important implications for access given the m

The Week in Review: Jan 6, 2017 – Jan 13, 2017

Friday, January 13, 2017 News Recap Close to Home This last week has seen some pretty sad news for Canadians with Hep C.  As you know, the Past Economic Loss and Dependents (PELD) Fund of the Pre-1986/Post-1990 Hepatitis C Settlement has a shortfall – with more than $65 million in unpaid claims. On December 15, 2016, a joint hearing was held in Toronto before the judges of Alberta, British Columbia, Ontario and Quebec to discuss the status of the...

Black, Hispanic HCV patients more likely to fail DAA therapy

Black and Hispanic patients with hepatitis C virus infection were less likely to achieve sustained virologic response with direct-acting antiviral agents compared with white patients within the U.S. Veterans Affairs health care system, according to recent study results. Further, black patients with HCV genotype 1 infection who were treated with Harvoni (ledipasvir/sofosbuvir, Gilead) monotherapy were significantly less likely to achieve SVR compared with